Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. Ferris SH, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S1-12. Alzheimer Dis Assoc Disord. 1997. PMID: 9236947 Clinical Trial.
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Bodick N, Forette F, Hadler D, Harvey RJ, Leber P, McKeith IG, Riekkinen PJ, Rossor MN, Scheltens P, Shimohama S, Spiegel R, Tanaka S, Thal LJ, Urata Y, Whitehouse P, Wilcock G. Bodick N, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:50-3. Alzheimer Dis Assoc Disord. 1997. PMID: 9305517
Clinical trials in Alzheimer disease: debate on the use of placebo controls.
Kawas CH, Clark CM, Farlow MR, Knopman DS, Marson D, Morris JC, Thal LJ, Whitehouse PJ. Kawas CH, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):124-9. doi: 10.1097/00002093-199907000-00002. Alzheimer Dis Assoc Disord. 1999. PMID: 10485569 Free article. Review.
Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ. Sano M, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1996 Fall;10(3):132-40. doi: 10.1097/00002093-199601030-00004. Alzheimer Dis Assoc Disord. 1996. PMID: 8876776 Clinical Trial.
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Mohs RC, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21. Alzheimer Dis Assoc Disord. 1997. PMID: 9236948
The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ. Sano M, et al. Among authors: thal lj. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S57-64. Alzheimer Dis Assoc Disord. 1997. PMID: 9236954
510 results